ARTICLE | Company News

uniQure CEO Soland resigns

September 22, 2016 7:00 AM UTC

Gene therapy company uniQure N.V. (NASDAQ:QURE) said CEO Daniel Soland resigned "due solely to personal family reasons." CFO Matthew Kapusta will be interim CEO, and will remain CFO. uniQure said it will not yet start a search for a permanent CEO while it adjusts its corporate strategy. ...